Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Am J Med Genet B Neuropsychiatr Genet
4 Biol Psychiatry
3 Mol Psychiatry
2 Neurosci Lett
4 Psychiatry Res
2 Psychol Med
7 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med Genet B Neuropsychiatr Genet

  1. WANG P, Li M, Zhao A, Ma J, et al
    Application of animal experimental models in the research of schizophrenia.
    Am J Med Genet B Neuropsychiatr Genet. 2021 Jun 22. doi: 10.1002/ajmg.b.32863.
    PubMed         Abstract available

    Biol Psychiatry

  2. HOFFMAN GE, Ma Y, Montgomery KS, Bendl J, et al
    Sex Differences in the Human Brain Transcriptome of Cases With Schizophrenia.
    Biol Psychiatry. 2021 Mar 25. pii: S0006-3223(21)01180.
    PubMed         Abstract available

    Serum NMDA Receptor Antibodies Do Not Predict Treatment Response in a Sample of People With First-Episode Psychosis.
    Biol Psychiatry. 2021;90:e1-e2.

  4. GOZES I
    A Different Outlook at Psychiatric and Neurological Diseases: Brain Somatic Mutations Are Implicated in Schizophrenia.
    Biol Psychiatry. 2021;90:6-8.

  5. STEFANSSON H, Stefansson K
    Cognition in Schizophrenia.
    Biol Psychiatry. 2021;90:4-5.

    Mol Psychiatry

  6. RADHAKRISHNAN R, Skosnik PD, Ranganathan M, Naganawa M, et al
    In vivo evidence of lower synaptic vesicle density in schizophrenia.
    Mol Psychiatry. 2021 Jun 16. pii: 10.1038/s41380-021-01184.
    PubMed         Abstract available

  7. ROGDAKI M, Devroye C, Ciampoli M, Veronese M, et al
    Correction: Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
    Mol Psychiatry. 2021 Jun 22. pii: 10.1038/s41380-021-01192.

  8. GAO WJ, Yang SS, Mack NR, Chamberlin LA, et al
    Aberrant maturation and connectivity of prefrontal cortex in schizophrenia-contribution of NMDA receptor development and hypofunction.
    Mol Psychiatry. 2021 Jun 23. pii: 10.1038/s41380-021-01196.
    PubMed         Abstract available

    Neurosci Lett

    The endocannabinoid system as a therapeutic target for schizophrenia: failures and potentials.
    Neurosci Lett. 2021 Jun 16:136064. doi: 10.1016/j.neulet.2021.136064.
    PubMed         Abstract available

  10. PATRIK S, Filip S
    Brain ventricular volume changes in schizophrenia. A narrative review.
    Neurosci Lett. 2021 Jun 16:136065. doi: 10.1016/j.neulet.2021.136065.
    PubMed         Abstract available

    Psychiatry Res

  11. KETHARANATHAN T, Pereira A, Reets U, Walker D, et al
    Brain changes in NF-kappaB1 and epidermal growth factor system markers at peri-pubescence in the spiny mouse following maternal immune activation.
    Psychiatry Res. 2021;295:113564.
    PubMed         Abstract available

  12. CAMUS D, Dan Glauser ES, Gholamrezaee M, Gasser J, et al
    Factors associated with repetitive violent behavior of psychiatric inpatients.
    Psychiatry Res. 2021;296:113643.
    PubMed         Abstract available

  13. MORRIS E, Batallones R, Ryan J, Slomp C, et al
    Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
    Psychiatry Res. 2021;296:113663.
    PubMed         Abstract available

  14. SREERAJ VS, Holla B, Ithal D, Nadella RK, et al
    Psychiatric symptoms and syndromes transcending diagnostic boundaries in Indian multiplex families: The cohort of ADBS study.
    Psychiatry Res. 2021;296:113647.
    PubMed         Abstract available

    Psychol Med

  15. CZEPIELEWSKI LS, Alliende LM, Castaneda CP, Castro M, et al
    Effects of socioeconomic status in cognition of people with schizophrenia: results from a Latin American collaboration network with 1175 subjects.
    Psychol Med. 2021 Jun 23:1-12. doi: 10.1017/S0033291721002403.
    PubMed         Abstract available

  16. SCHOFIELD P, Das-Munshi J, Webb RT, Horsdal HT, et al
    Lack of fit with the neighbourhood social environment as a risk factor for psychosis - a national cohort study.
    Psychol Med. 2021 Jun 18:1-9. doi: 10.1017/S0033291721002233.
    PubMed         Abstract available

    Schizophr Res

  17. RABINOWITZ J, Opler M, Rabinowitz AA, Negash S, et al
    Consistency checks to improve measurement with the Personal and Social Performance Scale (PSP).
    Schizophr Res. 2021;228:529-533.
    PubMed         Abstract available

  18. SUHAS S, Nagpal M, Rao NP, Kumar V, et al
    Echo of reading - The forgotten psychopathology: A case report.
    Schizophr Res. 2021;228:602-603.

  19. SUMNER PJ, Rossell SL, Tan EJ
    On the assessment of subjective formal thought disorder.
    Schizophr Res. 2021;228:58-59.

  20. DAS D, Peng X, Lam AN, Bader JS, et al
    Transcriptome analysis of human induced excitatory neurons supports a strong effect of clozapine on cholesterol biosynthesis.
    Schizophr Res. 2021;228:324-326.
    PubMed         Abstract available

  21. LAHTEENVUO M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, et al
    Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients.
    Schizophr Res. 2021;228:367-372.
    PubMed         Abstract available

  22. KOLBAEK P, Dines D, Hansen J, Opler M, et al
    Standardized training in the rating of the six-item Positive And Negative Syndrome Scale (PANSS-6).
    Schizophr Res. 2021;228:438-446.
    PubMed         Abstract available

  23. MALHI GS, Bell E, Hamilton A, Morris G, et al
    Early intervention for risk syndromes: What are the real risks?
    Schizophr Res. 2021;227:4-9.

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.